Advisory Committees

Health care teams, government agencies, community-based organizations, professional associations, and other key partners are coming together to support this initiative to make California’s communities ACEs Aware.

Get Updates from ACEs Aware >

smiling young male patient being held by smiling father gives a high-five to a smiling female doctor

Trauma-Informed Primary Care Implementation Advisory Committee

The purpose of the California Surgeon General’s Trauma-Informed Primary Care (TIPC) Implementation Advisory Committee is to advise the Office of the California Surgeon General and the Department of Health Care Services on the promising models, best practices, evolving science and clinical expertise for the implementation of trauma-informed care systems in California.

This includes prevention of and screening for ACEs in primary and specialty care, as well as integrated response including mental and behavioral health services, care coordination, and advancement of diagnostic tools and services to address toxic stress.

  • American Academy of Pediatrics
  • Anthem Blue Cross
  • Blue Shield of California
  • Blue Shield of California Foundation
  • California Academy of Family Physicians
  • California Behavioral Health Directors Association
  • California Conference of Local Health Officers
  • California Department of Health and Human Services
  • California Department of Public Health
  • California Department of Social Services
  • California Governor’s Office of Planning & Research
  • California Health Care Foundation
  • California Maternal Quality Care Collaborative
  • California Medical Association
  • California Pan-Ethnic Health Network
  • California Primary Care Association
  • California State Association of Counties
  • Californians for Safety & Justice
  • Center for Youth Wellness
  • County Health Executives Association of California
  • County Welfare Directors Association of California
  • Didi Hirsch Mental Health Services
  • First 5 California
  • HealthNet
  • Kaiser Permanente
  • L.A. Care Health Plan
  • Sutter Health
  • The California Endowment
  • The Permanente Medical Group
  • University of California, San Francisco

Click here for information on Trauma-Informed Primary Care (TIPC) Implementation Advisory Committee meetings.

Subcommittee Members

The Provider Engagement & Education Subcommittee provides strategic advice on increasing the number of providers who complete state-certified core ACE training and supporting providers in integrating ACE screening and clinical response into their practice.

  • Eric Ball, MD, FAAP – American Academy of Pediatrics – Orange County, California
  • Marti Baum, MD – California Medical Association – Board of Trustees
  • Kim Bower, MD – Blue Shield of California Promise Health Plan
  • Michelle Cabrera – California Behavioral Health Directors Association
  • Yvonne Choong, MPP (Co-Chair) – California Medical Association
  • Jerri Davis, CHCP – California Academy of Family Physicians
  • Lishaun Francis, MPP – Children Now
  • Carey Watson, MD, FACOG – Kaiser Permanente TPMG
  • Amber Kemp, MBA – California Association of Health Plans
  • Lisa James – Futures Without Violence
  • Stephen Lockhart, MD, PhD – Sutter Health
  • Brigid McCaw, MD, MPH, MS, FACP – CALQIC
  • Demetria Malloy, MD, MSHS (Co-Chair) – Anthem Blue Cross
  • Mike Witte, MD – California Primary Care Association

The Clinical Implementation Subcommittee provides input and clinical expertise on developing guidance and tools to help providers: a) Better understand toxic stress physiology and ACE-Associated Health Conditions (AAHCs); b) Implement ACE screenings, evidence-based interventions, and trauma-informed care; and c) Reduce health disparities.

  • Leon Altamirano, PsyD – North County Health Services
  • Deirdre Bernard-Pearl, MD – Santa Rosa Community Clinics
  • Tanya Dansky, MD (Facilitator) – ACEs Aware Clinical Advisor
  • Ken Epstein, PhD – University of California, San Francisco
  • Liza Eshilian-Oates, MD – Kaiser Permanente Southern California
  • Mike Flaningam, MD – Sutter Medical Group, Sacramento
  • Rachel Gilgoff, MD, MPH, FAAP – Stanford University
  • Nancy Goler, MD – Permanente Medical Group
  • Lisa Gutierrez Wang, PhD – County of Santa Cruz
  • Simone Ippoliti, PNP – Bayview Family Health Center
  • Dayna Long, MD – UCSF Benioff Children’s Hospital Oakland
  • Chris Longhurst, MD – University of California, San Diego
  • Eddy Machtinger, MD – University of California, San Francisco Medical School
  • Brigid McCaw, MD, MS, MPH – Senior Clinical Advisor, CALQIC, University of California, San Francisco
  • Connie Mitchell, MD, MPH – California Department of Public Health
  • Matt Pantell, MD, MS – University of California, San Francisco
  • Rachel, MD – FPA Women’s Health
  • Adia Scrubb, MD, MPP – California Academy of Family Physicians
  • Shannon Thyne, MD – University of California, Los Angeles Children’s Hospital
  • Linda Zane, MSN-FNP – Hill Country Community Clinic

The Network of Care Subcommittee recommends roadmaps for improving collaboration and coordination across the health care and social service system – between health plans, health centers, clinicians, and clinical and community organizations in responding to identification of ACEs in primary care.

  • Frank Mecca (Co-Chair)
  • Mary Ann Hansen (Co-Chair) – First 5 Association of California
  • Edward Machtinger, MD – University of California, San Francisco
  • Jonathan Goldfinger, MD, MPH, FAAP – Chief Executive Officer, Didi Hirsch Mental Health Services
  • Michael Brodsky, MD – L.A. Care Health Plan
  • Yvonne Choong – California Medical Association
  • Center for Youth Wellness

With the Office of the California Surgeon General, the Clinical Advisory Subcommittee developed the online training curriculum to certify Medi-Cal providers to receive payment for screening Medi-Cal patients for ACEs. The Clinical Advisory Subcommittee also developed the ACE Screening Clinical Algorithm to help providers assess whether a patient is at low, intermediate or high risk of a toxic stress physiology, and how to incorporate ACE screening results into clinical care and follow-up plans.

  • Nadine Burke Harris, MD, MPH – California Surgeon General
  • Devika Bhushan, MD – Office of the California Surgeon General
  • Karen Mark, MD, MPH – California Department of Health Care Services
  • Connie Mitchell, MD, MPH – California Department of Public Health
  • Eddy Machtinger, MD – University of California, San Francisco Medical School
  • Alicia Lieberman, PhD – University of California, San Francisco Medical School
  • Leigh Kimberg, MD – University of California, San Francisco Medical School
  • Dayna Long, MD – University of California, San Francisco Benioff Children’s Hospital Oakland
  • Sheela Raja, PhD – University of Illinois at Chicago
  • Shairi Turner, MD, MPH – Florida Department of Health
  • Shannon Thyne, MD – University of California, Los Angeles Children’s Hospital
  • Leena Singh, DrPH, MPH – Center for Youth Wellness
  • Ken Epstein, PhD – University of California, San Francisco
  • Nancy Goler, MD – Permanente Medical Group
  • Brigid McCaw, MD, MS, MPH – Senior Clinical Advisor, CALQIC, University of California, San Francisco

END USER SUBLICENSE AGREEMENT

PLEASE READ CAREFULLY: This End User Sublicense Agreement (the “Agreement” or “Sublicense”) is a legally binding agreement between you (an individual or an entity, hereinafter “You” or “Sublicensee”) and the Department of Health Care Services (“DHCS”) for the use of the Pediatric ACEs and Related Life-events Screener (“PEARLS”) for children and adults up to the age of 21.

BY WAY OF DOWNLOADING, COPYING, ACCESSING, OR OTHERWISE USING THE PEARLS TOOL, YOU ARE AGREEING TO BE LEGALLY BOUND BY THE TERMS OF THIS AGREEMENT. IF YOU DO NOT AGREE TO BE BOUND BY THE TERMS OF THIS AGREEMENT, THEN YOU HAVE NO RIGHTS TO THE PEARLS TOOL AND MAY NOT DOWNLOAD, COPY, ACCESS, OR OTHERWISE THE PEARLS TOOL.

THE PEARLS TOOL IS PROTECTED BY COPYRIGHT LAWS AND IS OTHERWISE PROTECTED INTELLECTUAL PROPERTY. THE PEARLS TOOL IS LICENSED AND IS NOT SOLD.

    1. The PEARLS Tool. The PEARLS tool is a unique tool that assess for both Adverse Childhood Experiences (“ACEs”) such as abuse, neglect, and household challenges, and related events, such as discrimination, food insecurity, and community violence, thought to be risk factors for toxic stress. The PEARLS tool was made in the course of research under the auspices of the Children’s Hospital Research Center at Oakland (“BCHO”) and the University of California, San Francisco. BCHO has licensed the PEARLS tool to DHCS and provided DHCS with the right to sublicense the PEARLS tool.
    2. Sublicensee Attestation. By agreeing to this Agreement, You attest that You are a provider of health care services to Medi-Cal beneficiaries, a Medi-Cal Managed Care Plan, a Medi-Cal beneficiary, a parent or guardian of a Medi-Cal beneficiary, or an Electronic Health Records (“EHR”) vendor.
    3. The Sublicense. Subject to the terms of this agreement, DHCS hereby grants to Sublicensee a non-exclusive, royalty-free, non-assignable, non-transferable sublicense (the “Sublicense”) to the PEARLS tool. Under the Sublicense, Sublicensee may use the PEARLS tool as directed, and may save, download, print, copy, reproduce, or distribute the PEARLS tool to facilitate such use.
    4. Use in a Remote Patient Portal. The PEARLS tool was developed as a screener of risk for toxic stress and has been tested for safe, reliable screening when used during in-person (i.e., synchronous) visits. The questions and responses of the PEARLS tool may be administered using the EHR as structured data fields to facilitate record and follow-up. Because the PEARLS tool was never studied under asynchronous screening formats, DHCS cannot provide recommendations regarding its use in a remote patient portal. This includes information around safety and adequate windows of response. Sublicensee acknowledges that DHCS is not responsible for providing any recommendations regarding the use of the PEARLS tool in a remote patient portal, and that DHCS is not responsible for overseeing implementation and use of the PEARLS tool in a remote patient setting. This includes information around safety and adequate windows of response.
    5. Disclaimer of Warranty. This Sublicense and the associated PEARLS tool are provided WITHOUT WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR ANY OTHER WARRANTY, EXPRESS OR IMPLIED. DHCS MAKES NO REPRESENTATION OR WARRANTY THAT THE PEARLS TOOL WILL NOT INFRINGE ANY COPYRIGHT, PATENT, OR OTHER PROPRIETARY RIGHT.
    6. Limitations of Liability.
      1. IN NO EVENT WILL DHCS BE LIABLE FOR ANY INCIDENTAL, SPECIAL OR CONSEQUENTIAL DAMAGES RESULTING FROM EXERCISE OF THIS SUBLICENSE OR THE USE OF THE PEARLS TOOL.
      2. DHCS WILL NOT BE LIABLE FOR ANY LOST PROFITS, COSTS OF PROCURING SUBSTITUTE GOODS OR SERVICES, LOST BUSINESS, ENHANCED DAMAGES FOR INTELLECTUAL PROPERTY INFRINGEMENT OR ANY INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE OR OTHER SPECIAL DAMAGES SUFFERED BY SUBLICENSEE, JOINT VENTURES, AFFILIATES, OR DEVELOPMENT PARTNERS ARISING OUT OF OR RELATED TO THIS AGREEMENT. DHCS WILL NOT LIABLE FOR ANY CAUSES OF ACTION OF ANY KIND (INCLUDING TORT, CONTRACT, NEGLIGENCE, STRICT LIABILITY, AND BREACH OF WARRANTY) EVEN IF DHCS HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
    7. Indemnity and Duty to Defend. Sublicensee shall indemnify, defend, and hold harmless DHCS from and against all claims, actions, damages, losses, liabilities (or actions or proceedings with respect to any thereof), whether or not rightful, arising from any and all actions or claims by any third party or expenses related thereto (including, but not limited to, all legal expenses, court costs, and attorney’s fees incurred in investigating, preparing, serving as a witness in, or defending against, any such claim, action, or proceeding, commenced or threatened) to which DHCS and/or any employee, contractor, or agent acting on DHCS’s behalf may be subject, whether or not Sublicensee is a party to any pending or threatened litigation, which arise out of or are related to (i) claims and losses accruing or resulting to any person, firm or corporation who may be injured or damaged by Sublicensee’s use, reproduction, manufacture, sale, offer to sell, distribution, import, export, modification, public and private  performance/display, license, and disposition of the PEARLS tool; (ii) the incorrectness or breach of any of the representations, warranties, covenant or agreements of Sublicensee pertaining the PEARLS tool; or (iii) any intellectual property infringement, or any other type of actual or alleged infringement claim, arising out of Sublicensee’s use, reproduction, manufacture, sale, offer to sell, distribution, import, export, modification, public and private performance/display, license, and disposition of the PEARLS tool. This indemnity obligation shall apply irrespective of whether the infringement claim is based on a patent, trademark or copyright registration that issued after the effective date of this Agreement. DHCS reserves the right to participate in and/or control, at Sublicensee’s expense, any such infringement action brought against DHCS.
    8. Governing Law. This Agreement is to be interpreted and construed in accordance with the laws of the State of California.
    9. Miscellaneous
      1. The relationship between DHCS and Sublicensee established by this Agreement is that of independent contractors. No joint venture or partnership is established by this Agreement. Neither party is the agent, broker, partner, employee, or legal representative of the other for any purpose.
      2. The headings of any sections are inserted for convenience of reference only and are not intended to be part of, or to affect the meaning or interpretation of this Agreement.
      3. This Agreement embodies the entire understanding of DHCS and Sublicensee and supersedes all previous communications, representations or understandings, either oral or written, between them relating to the subject matter of this Agreement.
      4. In the event that any provision of this Agreement is unenforceable or held to be unenforceable, all other provisions of this Agreement have force and effect and will not be affected thereby.
      5. This Agreement may only be amended, modified, or supplemented by an agreement in writing signed by each party hereto.